Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

President-elect Donald Trump recently appointed former Paypal executive David Sacks as the White House’s first-ever czar for ...

U.S. healthcare organizations lose $1.9 million on average during each day of downtime following a ransomware attack, ...

Walgreens is reportedly exploring selling itself to private equity firm Sycamore Partners. It might be the right decision for ...

Congress released a stopgap funding bill with a significant healthcare package, and provider groups are reacting favorably.

This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive appointment ...

Each year, billions of dollars in benefits are unused. Uno Health hopes to change this with its recent launch of the Uno Savings Guide, a resource that helps people determine their eligibility for ...

Several healthcare provisions, including drug reforms, were left out of the government funding bill, angering some healthcare ...

Bristol Myers Squibb has won FDA approval for an injectable version of its blockbuster cancer immunotherapy Opdivo, a regulatory decision that gives patients a more convenient dosing option and ...

Ascension’s May cyberattack compromised 5.6 million patients’ personal and health information, including Social Security numbers, credit card numbers and addresses. However, there is no evidence that ...

ŌURA, a wearable device company, has secured $200 million in Series D funding to expand its product offerings, the company announced last week. ŌURA, which was founded in Finland in 2013, offers ...